Evidence map›Paper›PMID 34713259›Full record

ArticleFrontiers in genome editing2021

Efficient Targeted Mutagenesis Mediated by CRISPR-Cas12a Ribonucleoprotein Complexes in Maize.

Shujie Dong, Yinping Lucy Qin, Christopher A Vakulskas, Michael A Collingwood, Mariam Marand, Stephen Rigoulot, Ling Zhu, Yaping Jiang, Weining Gu, Chunyang Fan and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genome editing, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. CRISPR/Cas system-mediated transgene-free or DNA-free genome editing in plants.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Shujie DongSyngenta Crop Protection, Research Triangle Park, Durham, NC, United States.
Yinping Lucy QinSyngenta Crop Protection, Research Triangle Park, Durham, NC, United States.
Christopher A VakulskasIntegrated DNA Technologies, Coralville, IA, United States.
Michael A CollingwoodIntegrated DNA Technologies, Coralville, IA, United States.
Mariam MarandSyngenta Crop Protection, Research Triangle Park, Durham, NC, United States.
Stephen RigoulotSyngenta Crop Protection, Research Triangle Park, Durham, NC, United States.
Ling ZhuSyngenta Crop Protection, Research Triangle Park, Durham, NC, United States.
Yaping JiangSyngenta Crop Protection, Research Triangle Park, Durham, NC, United States.
Weining GuSyngenta Crop Protection, Research Triangle Park, Durham, NC, United States.
Chunyang FanSyngenta Crop Protection, Research Triangle Park, Durham, NC, United States.
Anna MangumSyngenta Crop Protection, Research Triangle Park, Durham, NC, United States.
Zhongying ChenSyngenta Crop Protection, Research Triangle Park, Durham, NC, United States.
Michele YarnallSyngenta Crop Protection, Research Triangle Park, Durham, NC, United States.
Heng ZhongSyngenta Crop Protection, Research Triangle Park, Durham, NC, United States.
Sivamani ElumalaiSyngenta Crop Protection, Research Triangle Park, Durham, NC, United States.
Liang ShiSyngenta Crop Protection, Research Triangle Park, Durham, NC, United States.
Qiudeng QueSyngenta Crop Protection, Research Triangle Park, Durham, NC, United States.
Triangle · USSyngenta (United States) · USIntegrated DNA Technologies (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in the development of CRISPR-Cas genome editing technologies have made it possible to perform targeted mutagenesis and precise gene replacement in crop plants. CRISPR-Cas9 and CRISPR-Cas12a are two main types of widely used genome editing systems. However, when CRISPR-Cas12a editing machinery is expressed from a transgene, some chromosomal targets encountered low editing frequency in important crops like maize and soybean. Here, we report efficient methods to directly generate genome edited lines by delivering Cas12a-gRNA ribonucleoprotein complex (RNP) to immature maize embryos through particle bombardment in an elite maize variety. Genome edited lines were obtained at ~7% frequency without any selection during regeneration

Indexed as

AsCas12aCRISPR-Cas12aLbCas12amaize genome editingmutant Cas12aribonucleoprotein delivery

Identifiers

PMID34713259
PMCPMC8525364
OpenAlexW3163825845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.